期刊文献+

阿托伐他汀对糖尿病大鼠胸主动脉TLR4表达影响的实验研究 被引量:2

Experimental Study of the Effect of Atorvastatin on the Expression of TLR4 in Aorta Thoracalis of the GK Mice
下载PDF
导出
摘要 目的观察GK大鼠胸主动脉TLR4表达及应用阿托伐他汀其表达水平的变化。探讨TLR4与动脉硬化的关系。方法分组:空白对照组;实验对照组;阿托伐他汀组,5周后应用RT-PCR、Western blot检测各组大鼠胸主动脉TLR4表达。结果实验对照组较空白对照组TLR4表达显著增高,阿托伐他汀组较实验对照组TLR4表达显著降低。结论阿托伐他汀可能通过降低TLR4表达,防治动脉粥样硬化。 Objective To observe the expression of TLR4 in aorta thoracalis of the GK mice and the change of that after using atorvastatin. Methods Mice were divided into control group, experimental control group, atorvastatin group. After five weeks, TLR4 was detected by using PT-PCR and Western blot method. Results The TLR4 level of experimental control group is higher than that of control group. The TLR4 level of atorvastatin group is lower than that of experimental control group(P〈 0.01). Conclusions Atorvastatin may prevent atherosclerosis through reducing TLR4 expression.
出处 《中国医药指南》 2014年第36期19-19,共1页 Guide of China Medicine
关键词 TLR4 阿托伐他汀 糖尿病 动脉硬化 TLR4 Atorvastatin Diabete Atherosclerosis
  • 相关文献

参考文献4

  • 1Hashimoto C,Hudsen KL,Anderson KV.The toll gene of Drosophila,required for dorsal ventral embryonic polarity,appears to encode a transmembrane protein[J].Cell,1988,52(3):269-279.
  • 2Ross R.Atherosclerosis-an inflammation disease[J].N Engl J Med,1999,340(2):115-126.
  • 3李慧,邹大进.2型糖尿病及肥胖与慢性炎症因子[J].第二军医大学学报,2003,24(11):1244-1246. 被引量:38
  • 4Cormier J,Cormier F,Fichelle J.Arterial disease of the lower limbs in diabeticpatients[J].Rev Prat,1995,45(1):50.

二级参考文献25

  • 1Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly[J]. Diabetes,2001,50(10):2384-2389.
  • 2Freeman DJ, Norrie J, Caslake MJ,et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study[J].Diabetes,2002,51(5) :1596-1600.
  • 3Festa A, D'Agostino R Jr, Howard G,et al. Chronic subclinical inflammation as part of the insulin resistance sydrome. The Insulin Resistance Atherosclerosis Study (IRAS) [J]. Circulation,2000,102(1) :42-47.
  • 4Frohlich M,Imhof A,Berg G,et al. Association between C-reactive protein and features of the metabolic syndrome:a population-based study [J]. Diabetes Care, 2000, 23 ( 12 ) : 1835-1839.
  • 5Visser M, Bouter LM, Geraldine MM, et al. Elevated C-reactive protein levels in overweight and obese adults[J], JAMA,1999,282(22) :2131-2135.
  • 6Calandra T, Bernhagen J, Mitchell RA,et al. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor[J], J Exp Med, 1994,179(6) :1895-1902.
  • 7Pickup JC,Mattock MB,Chusney GD,et al. NIDDM as a disease of the innate immune system: association of acute phase reaction and interleukin-6 with metabolic syndrome X[J].Diabetologia, 1997,40( 11 ) : 1286-1292.
  • 8Hrnciar J,Gabor D, Hrnciarova M, et al. Relation between cytokines(TNF-a,IL-1 and 6) and homocysteine in android obesity and the phenomenon of insulin resistance syndromes[J].Vnitr Lek, 1999,45(1) : 11-16.
  • 9Uysal KT, Wlesbrock SM, Marino MW, et al. Protection from obesity-induced insulin resistance in mice lacking TNF-a function[J]. Nature,1997,389(6651) :610-614.
  • 10Hotamisligil GS,Shargill NS,Spiegelman BM. Adipose expression of TNF-a:Direct role in obesity-linked insulin resistance[J]. Science, 1993,259(5091 ) :87-91.

共引文献37

同被引文献22

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部